33m
Hosted on MSNGuggenheim Initiates Coverage of Compass Therapeutics (CMPX) with Buy RecommendationFintel reports that on February 24, 2025, Guggenheim initiated coverage of Compass Therapeutics (NasdaqCM:CMPX) with a Buy recommendation. Analyst Price Forecast Suggests 266.05% Upside As of February ...
Rivian Automotive (NASDAQ:RIVN – Free Report) had its price target raised by Needham & Company LLC from $14.00 to $17.00 in a ...
Endava (NYSE:DAVA – Free Report) had its price target reduced by Susquehanna from $55.00 to $50.00 in a research note published on Friday,Benzinga reports. Susquehanna currently has a positive rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results